Connect Sign In
Amphetamines Urine Screen with Reflex to Quantitation
Ordering Recommendation
Useful for general screening in contexts of compliance and/or abuse. A screen with reflex testing is the preferred method for ruling out amphetamine exposure. For follow-up testing of a presumptive result, Amphetamines, Urine, Quantitative (2010075) is preferred.
New York DOH Approval Status
Specimen Required
Random urine.
Transfer 4.0 mL urine with no additives or preservatives to an ARUP Standard Transport Tube. (Min: 2.0 mL)
Room temperature.
Breast milk.
Ambient: 1week; Refrigerated: 1 month; Frozen: 1 month
Methodology
Qualitative Enzyme Immunoassay/Quantitative Liquid Chromatography-Tandem Mass Spectrometry
Performed
Sun-Sat
Reported
1-4 days
Reference Interval
Interpretive Data
Methodology: Immunoassay
Positive Cutoff: 300 ng/mL
FDA
Note
If the specimen screens positive, then Confirmation/Quantitation by LC-MS/MS (ARUP test code 2010075) will be added to confirm result. Additional charges apply.
Compare to Methamphetamine; Pain Management; Pain Management, Amphetamines, Quantitative, with medMATCH, Urine; Pain Management, Amphetamines, with Confirmation with medMATCH, Urine; Pain Management, MDMA/MDA, Quantitative, with medMATCH, Urine;
Hotline History
CPT Codes
80307; if reflexed, add 80325; 80359 (Reflexed Alt Code: G0480 )
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 0092191 | Amphetamines Screen, Urine | 19261-7 |
| 2012212 | Screen, Urine Interpretation | 54247-2 |
Aliases
- XTC
- Zelapor
- Desoxyephedrine
- Desoxyn
- Eldepryl
- Emsam
- Eve
- Lisdexamfetamine
- Paremyd
- Selegiline
- Vicks Inhaler
- Vyvanse
- Amphetamine
- MDA
- MDMA Confirmation, Urine
- Benzedrine
- Carbex
- Deprenyl
- Dexedrine
- Dextroamphetamine
- MDEA
- MDMA
- Ecstasy
